SNDX
Syndax Pharmaceuticals Inc
NASDAQ · Healthcare · Biotechnology · US
$10.45
−26.87%Margins
Gross margin
93.7%
EBITDA margin
-41.2%
EBIT margin
-61.7%
Net margin
-72.4%
FCF margin
-61.3%
1219.3%
Return on equity
-30.2%
Return on assets
-31.2%
Return on invested capital
0.41x
Asset turnover
-$177.4M
Cash from operations
$4.75
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Sep 1, 2026